IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 16 filers reported holding IO BIOTECH INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -21.3% | 19,917 | -3.1% | 0.00% | – |
| Q4 2022 | $47 | -100.0% | 20,554 | -46.4% | 0.00% | – |
| Q3 2022 | $104,000 | -51.9% | 38,322 | -17.1% | 0.00% | – |
| Q2 2022 | $216,000 | -43.9% | 46,231 | -36.4% | 0.00% | – |
| Q1 2022 | $385,000 | -24.8% | 72,728 | -6.7% | 0.00% | – |
| Q4 2021 | $512,000 | – | 77,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 3,640,015 | $4,258,818 | 0.89% |
| Pivotal bioVenture Partners Investment Advisor LLC | 864,197 | $1,011,110 | 0.78% |
| Vivo Capital, LLC | 6,173,439 | $7,222,924 | 0.67% |
| Novo Holdings A/S | 4,429,449 | $5,182,455 | 0.30% |
| PFM Health Sciences, LP | 2,341,107 | $2,739,095 | 0.14% |
| Logos Global Management LP | 493,827 | $577,778 | 0.05% |
| ARMISTICE CAPITAL, LLC | 1,545,000 | $1,807,650 | 0.02% |
| Soleus Capital Management, L.P. | 192,670 | $225,424 | 0.02% |
| Alyeska Investment Group, L.P. | 987,654 | $1,155,555 | 0.01% |
| Redwood Wealth Management Group, LLC | 4,166 | $4,874 | 0.00% |